Infective endocarditis: Prevention, diagnosis, and management

Canadian Journal of Cardiology

Volumn 30, Issue 9, 2014, Pages 1046-1057

  Thuny, Franck ^a   Grisoli, Dominique ^a   Cautela, Jennifer ^a   Riberi, Alberto ^a   Raoult, Didier ^a   Habib, Gilbert ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ASPERGILLUS; BACTERIAL ENDOCARDITIS; BARTONELLA; BLOOD CULTURE; BRAIN ABSCESS; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRUCELLA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COXIELLA BURNETII; FEVER; FOLLOW UP; HEART FAILURE; HEART VALVE PROSTHESIS; HUMAN; LEGIONELLA PNEUMOPHILA; MENINGITIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYCOPLASMA; NEUROLOGICAL COMPLICATION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SEPSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOOTH EXTRACTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY; ENDOCARDITIS; HUMANS; MOLECULAR IMAGING; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906241531     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.03.042     Document Type: Review

References (83)

1. van der Meer J.T., Thompson J., Valkenburg H.A., Michel M.F. Epidemiology of bacterial endocarditis in the netherlands. I. Patient characteristics. Arch Intern Med 1992, 152:1863-1868.
2. Berlin J.A., Abrutyn E., Strom B.L., et al. Incidence of infective endocarditis in the Delaware valley, 1988-1990. Am J Cardiol 1995, 76:933-936.
3. Hoen B., Alla F., Selton-Suty C., et al. Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002, 288:75-81.
4. Hogevik H., Olaison L., Andersson R., Lindberg J., Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995, 74:324-339.
5. Selton-Suty C., Celard M., Le Moing V., et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012, 54:1230-1239.
6. Cabell C.H., Pond K.K., Peterson G.E., et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001, 142:75-80.
7. Thuny F., Grisoli D., Collart F., Habib G., Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet 2012, 379:965-975.
8. Benito N., Miro J.M., de Lazzari E., et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009, 150:586-594.
9. Fowler V.G., Miro J.M., Hoen B., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
10. Sy R.W., Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 2010, 31:1890-1897.
11. Durack D.T. Prevention of infective endocarditis. NEngl J Med 1995, 332:38-44.
12. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736-1754.
13. Habib G., Hoen B., Tornos P., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009, 30:2369-2413.
14. Glauser M.P., Bernard J.P., Moreillon P., Francioli P. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. JInfect Dis 1983, 147:568-575.
15. Moreillon P., Wilson W.R., Leclercq R., Entenza J.M. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant enterococcus faecalis. Antimicrob Agents Chemother 2007, 51:1661-1665.
16. Forner L., Larsen T., Kilian M., Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. JClin Periodontol 2006, 33:401-407.
17. Lockhart P.B., Brennan M.T., Sasser H.C., et al. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008, 117:3118-3125.
18. Roberts G.J. Dentists are innocent! "Everyday" bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol 1999, 20:317-325.
19. Veloso T.R., Amiguet M., Rousson V., et al. Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infect Immun 2011, 79:2006-2011.
20. Oliver R., Roberts G.J., Hooper L., Worthington H.V. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2008, CD003813.
21. Van der Meer J.T., Van Wijk W., Thompson J., et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992, 339:135-139.
22. Imperiale T.F., Horwitz R.I. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990, 88:131-136.
23. Lacassin F., Hoen B., Leport C., et al. Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J 1995, 16:1968-1974.
24. Strom B.L., Abrutyn E., Berlin J.A., et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med 1998, 129:761-769.
25. Duval X., Alla F., Hoen B., et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 2006, 42:e102-e107.
26. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003, 12:195-202. International Collaborative Study of Severe Anaphylaxis.
27. Lee P., Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. JAntimicrob Chemother 2007, 60:1172-1173.
28. Bombassaro A.M., Wetmore S.J., John M.A. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. JCan Dent Assoc 2001, 67:20-22.
29. Danchin N., Duval X., Leport C. Prophylaxis of infective endocarditis: French recommendations 2002. Heart 2005, 91:715-718.
30. Richey R., Wray D., Stokes T. Prophylaxis against infective endocarditis: Summary of NICE guidance. BMJ 2008, 336:770-771.
31. Thornhill M.H., Dayer M.J., Forde J.M., et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ 2011, 342:d2392.
32. Duval X., Delahaye F., Alla F., et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. JAm Coll Cardiol 2012, 59:1968-1976.
33. Desimone D.C., Tleyjeh I.M., Correa de Sa D.D., et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation 2012, 126:60-64.
34. Martin M.V., Longman L.P., Forde M.P., Butterworth M.L. Infective endocarditis and dentistry: the legal basis for an association. Br Dent J 2007, 203:E1. [discussion: 38-9].
35. Chen S.J., Liu C.J., Chao T.F., et al. Dental scaling and atrial fibrillation: a nationwide cohort study. Int J Cardiol 2013, 168:2300-2303.
36. von Reyn F.C., Arbeit R.D., Friedland G.H., Crumpacker C.S. Criteria for the diagnosis of infective endocarditis. Clin Infect Dis 1994, 19:368-370.
37. Durack D.T., Lukes A.S., Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96:200-209.
38. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
39. Thuny F., Di Salvo G., Belliard O., et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005, 112:69-75.
40. Raoult D., Casalta J.P., Richet H., et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. JClin Microbiol 2005, 43:5238-5242.
41. Fournier P.E., Thuny F., Richet H., et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010, 51:131-140.
42. Lepidi H., Coulibaly B., Casalta J.P., Raoult D. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. JInfect Dis 2006, 193:1711-1717.
43. Vieira M.L., Grinberg M., Pomerantzeff P.M., Andrade J.L., Mansur A.J. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart 2004, 90:1020-1024.
44. Habib G., Badano L., Tribouilloy C., et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr 2010, 11:202-219.
45. Khatib R., Sharma M. Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia. Medicine (Baltimore) 2013, 92:182-188.
46. Palraj B.R., Sohail M.R. Appropriate use of echocardiography in managing Staphylococcus aureus bacteremia. Expert Rev Anti Infect Ther 2012, 10:501-508.
47. Fagman E., Perrotta S., Bech-Hanssen O., et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol 2012, 22:2407-2414.
48. Feuchtner G.M., Stolzmann P., Dichtl W., et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. JAm Coll Cardiol 2009, 53:436-444.
49. Gahide G., Bommart S., Demaria R., et al. Preoperative evaluation in aortic endocarditis: findings on cardiac CT. AJR Am J Roentgenol 2010, 194:574-578.
50. Duval X., Iung B., Klein I., et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010, 152:497-504.
51. Cooper H.A., Thompson E.C., Laureno R., et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 2009, 120:585-591.
52. Iung B., Klein I., Mourvillier B., et al. Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. Eur Heart J Cardiovasc Imaging 2012, 13:703-710.
53. Sarrazin J.F., Philippon F., Tessier M., et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. JAm Coll Cardiol 2012, 59:1616-1625.
54. Saby L., Le Dolley Y., Laas O., et al. Early diagnosis of abscess in aortic bioprosthetic valve by 18F-fluorodeoxyglucose positron emission tomography-computed tomography. Circulation 2012, 126:e217-e220.
55. Saby L., Laas O., Habib G., et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular (18)f-fluorodeoxyglucose uptake as a novel major criterion. JAm Coll Cardiol 2013, 61:2374-2382.
56. Bensimhon L., Lavergne T., Hugonnet F., et al. Whole body [(18) f]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect 2010, 17:836-844.
57. Ploux S., Riviere A., Amraoui S., et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm 2011, 8:1478-1481.
58. Erba P.A., Conti U., Lazzeri E., et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. JNucl Med 2012, 53:1235-1243.
59. Hyafil F., Rouzet F., Lepage L., et al. Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. Eur Heart J Cardiovasc Imaging 2013, 14:586-594.
60. Panizzi P., Nahrendorf M., Figueiredo J.L., et al. Invivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med 2011, 17:1142-1146.
61. Thuny F., Gaubert J.Y., Jacquier A., et al. Imaging investigations in infective endocarditis: current approach and perspectives. Arch Cardiovasc Dis 2013, 106:52-62.
62. Thuny F., Beurtheret S., Mancini J., et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011, 32:2027-2033.
63. Botelho-Nevers E., Thuny F., Casalta J.P., et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009, 169:1290-1298.
64. Thuny F., Botelho E., Casalta J.P., et al. Can we really achieve a 1-year mortality rate lower than 10% in patients with infective endocarditis?. Arch Intern Med 2010, 170:211-212.
65. Chambers J., Sandoe J., Ray S., et al. The infective endocarditis team: recommendations from an international working group. Heart 2014, 100:524-527.
66. Dickerman S.A., Abrutyn E., Barsic B., et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007, 154:1086-1094.
67. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America [errata in 2005;112:2373, 2007;115:e408, 2007;116:e547, 2008;118:e497]. Circulation 2005, 111:e394-434.
68. Chu V.H., Cabell C.H., Benjamin D.K., et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004, 109:1745-1749.
69. Hasbun R., Vikram H.R., Barakat L.A., Buenconsejo J., Quagliarello V.J. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003, 289:1933-1940.
70. San Roman J.A., Lopez J., Vilacosta I., et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med 2007, 120:369.e1-369.e7.
71. Turak O., Ozcan F., Isleyen A., et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol 2013, 29:1672-1678.
72. Thuny F., Habib G. When should we operate on patients with acute infective endocarditis?. Heart 2010, 96:892-897.
73. Kang D.H., Kim Y.J., Kim S.H., et al. Early surgery versus conventional treatment for infective endocarditis. NEngl J Med 2012, 366:2466-2473.
74. Alexiou C., Langley S.M., Stafford H., et al. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000, 69:1448-1454.
75. Jault F., Gandjbakhch I., Rama A., et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 1997, 63:1737-1741.
76. Sy R.W., Chawantanpipat C., Richmond D.R., Kritharides L. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur Heart J 2009, 32:2016-2036.
77. Lopez J., Fernandez-Hidalgo N., Revilla A., et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart 2011, 97:1138-1142.
78. Hubert S., Thuny F., Resseguier N., et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. JAm Coll Cardiol 2013, 62:1384-1392.
79. Thuny F., Avierinos J.F., Tribouilloy C., et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 2007, 28:1155-1161.
80. Snygg-Martin U., Gustafsson L., Rosengren L., et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008, 47:23-30.
81. Garcia-Cabrera E., Fernandez-Hidalgo N., Almirante B., et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 2013, 127:2272-2284.
82. Peters P.J., Harrison T., Lennox J.L. Adangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis 2006, 6:742-748.
83. Thuny F., Giorgi R., Habachi R., et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 2012, 164:94-101.